Latest papers

[Recent progress of strategy of the therapy for the complication of ACS].

[Amiodarone-induced thyroid gland dysfunctions].

Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.

[Acute myocardial infarction following persistent atrial fibrillation. Consequence, common etiology or a case?].

How toxic is amiodarone to the liver?

[Drug-induced pulmonary interstitial disease]

The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.

Amiodarone-induced loculated pleural effusion: case report and review of the literature.

Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats.

[Upstream approach for atrial fibrillation].

Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.

[Comparison of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. Indirect meta-analysis]

Amiodarone-induced liver cirrhosis and parkinsonism: a case report.

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.

Atrial fibrillation: Dronedarone and amiodarone-the safety versus efficacy debate.

[Ionic mechanisms of action of class III antiarrhythmic drugs].

Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery.

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction.

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years.